MINNEAPOLIS - (Mealey's) The third Levaquin multidistrict litigation tendon rupture trial ended Jan. 26 with a defense verdict, defendant Johnson & Johnson's third compared to one plaintiff victory ( Clifford Straka v. Johnson & Johnson... Read More
ATLANTIC CITY, N.J. - (Mealey's) The first trial in New Jersey's Levaquin mass tort litigation ended Oct. 14 with a defense verdict for Johnson & Johnson and subsidiary Ortho-McNeil-Janssen Pharmaceuticals Inc. ( Paul Gaffney v. Johnson &... Read More
AUSTIN, Texas -- Johnson & Johnson subsidiary Janssen LLP said Jan. 19 that it has agreed to pay $158 million to settle claims by Texas that it defrauded the Medicaid program through its off-label promotion of the atypical antipsychotic drug Risperdal... Read More
NEW BRUNSWICK, N.J. - (Mealey's) A Risperdal personal injury trial ended Feb. 16 in a defense verdict for Johnson & Johnson subsidiary Janssen Pharmaceuticals Inc. after a New Jersey state court jury found that Janssen failed to warn about the... Read More
By Amy M. Smith On March 21, 2012, the United States Supreme Court decided Sackett v. Environmental Protection Agency , No. 10-1062 [ enhanced version available to lexis.com subscribers ]. The Court held that individuals may bring a civil action under... Read More
ATLANTIC CITY, N.J. - (Mealey's) A New Jersey court on Feb. 26 is hearing evidence for a punitive damages verdict in the state's first pelvic mesh bellwether trial, a day after returning a $3.35 million compensatory verdict for a woman who claims... Read More
LOS ANGELES - (Mealey's) A California state court jury on Oct. 3 awarded $48.1 million to a 22-year-old man who says Johnson & Johnson and subsidiary McNeil Consumer Healthcare failed to warn him that the nonprescription pain and fever remedy... Read More
On Aug. 14, a panel of experts including Yun Lee, Associate General Counsel, AIG, Michael Miller of Steptoe & Johnson LLP, and Gonzalo Zeballos of Baker & Hostetler LLP will discuss the topics below and more, as well as take your questions during... Read More
NEW BRUNSWICK, N.J. - (Mealey's) Johnson & Johnson (J&J) expects to incur a special charge against earnings of about $600 million in the second quarter for the potential settlement of civil litigation related to Risperdal, Invega, Natrecor... Read More
LITTLE ROCK, Ark. - (Mealey's) An Arkansas state court judge on April 11 assessed a $1.1 billion penalty against the Ortho-McNeil-Janssen Pharmaceuticals Inc. subsidiary of Johnson & Johnson for thousands of violations of state trade practice... Read More
BROCKTON, Mass. - (Mealey's) A Massachusetts state court jury on Feb. 13 awarded $63 million to a family whose young daughter was severely injured by a reaction to Children's Motrin ( Lisa Reckis, et al. v. Johnson & Johnson, et al. , No.... Read More
SAN FRANCISCO -- The Scios Inc. subsidiary of Johnson & Johnson has agreed to plead guilty to a misdemeanor charge related to the off-label marketing of its Natrecor heart drug, to pay an $85 million fine and to serve three years' organizational... Read More